156 related articles for article (PubMed ID: 31865473)
1. Case-control study of endogenous sex steroid hormones and risk of endometrial cancer.
Friedenreich CM; Derksen JWG; Speidel T; Brenner DR; Heer E; Courneya KS; Cook LS
Cancer Causes Control; 2020 Feb; 31(2):161-171. PubMed ID: 31865473
[TBL] [Abstract][Full Text] [Related]
2. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Allen NE; Key TJ; Dossus L; Rinaldi S; Cust A; Lukanova A; Peeters PH; Onland-Moret NC; Lahmann PH; Berrino F; Panico S; Larrañaga N; Pera G; Tormo MJ; Sánchez MJ; Ramón Quirós J; Ardanaz E; Tjønneland A; Olsen A; Chang-Claude J; Linseisen J; Schulz M; Boeing H; Lundin E; Palli D; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Bingham S; Khaw KT; Bueno-de-Mesquita HB; Trichopoulou A; Trichopoulos D; Naska A; Tumino R; Riboli E; Kaaks R
Endocr Relat Cancer; 2008 Jun; 15(2):485-97. PubMed ID: 18509001
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
[TBL] [Abstract][Full Text] [Related]
10. Neighborhood walkability and sex steroid hormone levels in women.
India-Aldana S; Rundle AG; Clendenen TV; Quinn JW; Arslan AA; Afanasyeva Y; Koenig KL; Liu M; Neckerman KM; Thorpe LE; Zeleniuch-Jacquotte A; Chen Y
Environ Res; 2022 Dec; 215(Pt 2):114285. PubMed ID: 36088991
[TBL] [Abstract][Full Text] [Related]
11. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
12. Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
Holl K; Lundin E; Surcel HM; Grankvist K; Koskela P; Dillner J; Hallmans G; Wadell G; Olafsdottir GH; Ogmundsdottir HM; Pukkala E; Lehtinen M; Stattin P; Lukanova A
Int J Cancer; 2009 Jun; 124(12):2923-8. PubMed ID: 19330837
[TBL] [Abstract][Full Text] [Related]
13. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Lukanova A; Lundin E; Zeleniuch-Jacquotte A; Muti P; Mure A; Rinaldi S; Dossus L; Micheli A; Arslan A; Lenner P; Shore RE; Krogh V; Koenig KL; Riboli E; Berrino F; Hallmans G; Stattin P; Toniolo P; Kaaks R
Eur J Endocrinol; 2004 Feb; 150(2):161-71. PubMed ID: 14763914
[TBL] [Abstract][Full Text] [Related]
14. Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
Sherman ME; Madigan MP; Lacey JV; Garcia-Closas M; Potischman N; Carreon JD; Hartge P; Brinton LA
Gynecol Oncol; 2007 Dec; 107(3):431-5. PubMed ID: 17720234
[TBL] [Abstract][Full Text] [Related]
15. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
Key T; Appleby P; Barnes I; Reeves G;
J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
18. Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
Lundin E; Wirgin I; Lukanova A; Afanasyeva Y; Krogh V; Axelsson T; Hemminki K; Clendenen TV; Arslan AA; Ohlson N; Sieri S; Roy N; Koenig KL; Idahl A; Berrino F; Toniolo P; Hallmans G; Försti A; Muti P; Lenner P; Shore RE; Zeleniuch-Jacquotte A
Cancer Epidemiol; 2012 Oct; 36(5):445-52. PubMed ID: 22633539
[TBL] [Abstract][Full Text] [Related]
19. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
Lønning PE; Helle SI; Johannessen DC; Adlercreutz H; Lien EA; Tally M; Ekse D; Fotsis T; Anker GB; Hall K
Clin Endocrinol (Oxf); 1995 Jan; 42(1):23-30. PubMed ID: 7534218
[TBL] [Abstract][Full Text] [Related]
20. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States).
Madigan MP; Troisi R; Potischman N; Dorgan JF; Brinton LA; Hoover RN
Cancer Causes Control; 1998 Mar; 9(2):199-207. PubMed ID: 9578297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
